Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | 0.00% | 0.00% | -35.00% |
04-19 | Subchapter V Trustee Appointed Under Chapter 11 for Histogen Inc. | CI |
04-18 | Histogen Inc. Filed for Bankruptcy | CI |
Sales 2021 | 1.03M 1.41M | Sales 2022 | 3.77M 5.15M | Capitalization | 3.55M 4.84M |
---|---|---|---|---|---|
Net income 2021 | -15M -20.48M | Net income 2022 | -10M -13.65M | EV / Sales 2021 | 2.62 x |
Net cash position 2021 | 13.92M 19M | Net cash position 2022 | 7.48M 10.21M | EV / Sales 2022 | -1.04 x |
P/E ratio 2021 |
-0.85
x | P/E ratio 2022 |
-0.24
x | Employees | 7 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.15% |
Current month | -43.04% | ||
1 month | -60.00% | ||
3 months | -40.30% | ||
6 months | -36.51% | ||
Current year | -35.00% |
Managers | Title | Age | Since |
---|---|---|---|
Susan Knudson
CEO | Chief Executive Officer | 60 | 20-05-26 |
Mark A. Hubka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas L. Hubka
PRN | Corporate Officer/Principal | 37 | 20-05-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Kisner
CHM | Chairman | 77 | 14-01-31 |
Director/Board Member | 54 | 21-03-24 | |
David Crean
BRD | Director/Board Member | 59 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.2 | 0.00% | 200 |
24-05-10 | 0.2 | 0.00% | 170 |
24-05-08 | 0.2 | +25.00% | 735 |
24-05-07 | 0.16 | +6.67% | 424 |
Delayed Quote OTC Markets, May 15, 2024 at 09:30 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.00% | 854K | |
+5.50% | 111B | |
+11.71% | 106B | |
-12.40% | 22.24B | |
+0.17% | 21.25B | |
-4.92% | 18.97B | |
-35.21% | 18.52B | |
-11.16% | 16.81B | |
+37.49% | 12.54B | |
-24.76% | 8.09B |
- Stock Market
- Equities
- HSTO Stock